Protalix BioTherapeutics to Hold Second Quarter 2017 Financial Results and Corporate Update Conference Call on August 9, 2017

World News: . []

CARMIEL Israel July 31 2017 GLOBE NEWSWIRE) -- Protalix BioTherapeutics Inc NYSE AmericanPLX TASEPLX a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through it s propr...

More news and information about Protalix BioTherapeutics, Inc.

Published By:

Globe Newswire: 12:30 GMT Monday 31st July 2017

Published: .

Search for other references to "protalix" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us